Statement | 14 September 2014 Hepatitis C India MSF Access Campaign response to Gilead’s deal with generic companies for sofosbuvir and ledipasvir 6 min
Statement | 27 August 2014 Hepatitis C Hepatitis C drug daclatasvir approved by European Commission 3 min
Statement | 17 July 2014 Intellectual property and trade United States of AmericaIndia MSF responds to US renewed attacks on India’s patent regime 3 min
Statement | 16 July 2014 HIV/AIDS MSF response to UNAIDS' Gap report on the state of the HIV epidemic
Statement | 15 July 2014 Tuberculosis MSF calls on BRICS countries to prioritize health and access to medical innovation 5 min
Statement | 23 May 2014 Intellectual property and trade Access to Essential Medicines - MSF intervention at 67th World Health Assembly
Statement | 22 May 2014 Research and development MSF intervention on the report of the CEWG on R&D at 67th WHA
Statement | 21 May 2014 Hepatitis C Preparedness, surveillance and response: Hepatitis. MSF intervention at 67th WHA
